# Diuretic Versus Placebo in Pulmonary Embolism

Study · id `cardio:ct-nct02268903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02268903](<https://clinicaltrials.gov/study/NCT02268903>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02268903

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 270 participants.

## Technical summary

Registry record NCT02268903. Randomized; quadruple masking; primary purpose treatment. Start 2015-04-13 (actual); primary completion 2018-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 270 participants (planned count; ClinicalTrials.gov record NCT02268903, source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)
- Started: 2015-04-13 (actual) (ClinicalTrials.gov record NCT02268903, source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)
- Primary completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT02268903, source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)
- Completion: 2018-05 (anticipated) (ClinicalTrials.gov record NCT02268903, source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT02268903, source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02268903-2017-10-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: Diuretic Versus Placebo in Pulmonary Embolism
- Acronym: DiPER
- Condition: Pulmonary Embolism With Right Ventricle Enlargement
- Intervention (Drug): Diuretics : Furosemide
- Intervention (Drug): Placebo
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial (`cardio:pubmed-34632490`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ab83892986a15005fa6bf7d52975bddd15f4d7b465ab2212020780ec587b0b96
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
